How to perform microwave thermotherapy in the office
Benign prostatic hyperplasia afflicts millions of men throughout the world, with an overall prevalence of histologic BPH at autopsy of 50% by age 60 years and 90% by age 85 years (J Urol 1984; 132:474-9). Surgery, although effective, includes a 1% to 3% incidence of mortality.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.